Treatment for atrophic macular degeneration

Area of Science:

• Ophthalmology
• Retinal Diseases
• Clinical Trials

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss.
• Geographic atrophy (GA) is an advanced form of AMD characterized by progressive retinal cell death.
• Current treatment options for GA are limited.

Purpose of the Study:

• To provide a comprehensive summary of ongoing and recently completed clinical trials for geographic atrophy (GA).
• To review the landscape of investigational agents targeting GA associated with age-related macular degeneration (AMD).

Main Methods:

• Systematic review of clinical trial databases.
• Analysis of recently completed and ongoing studies.
• Inclusion of trials in pre-clinical and early-phase clinical testing.

Main Results:

• A substantial number of investigational agents are currently under development for GA treatment.
• These agents are in various stages of clinical testing, from pre-clinical to early-phase trials.
• The development pipeline includes therapies targeting diverse aspects of GA pathogenesis.

Conclusions:

• Multiple therapeutic strategies are being explored for geographic atrophy.
• Despite extensive research and development, no treatments have yet demonstrated efficacy.
• Further research is needed to identify effective therapies for GA.